Differential effect of peroxisome proliferator-activated receptor-α agonists on fatty acid composition in human hepatoma cell line, HepG2

被引：0
|
作者：
Yousefi, Bahman [1 ]
Darabi, Masoud [1 ]
Rahbani, Mohammad [1 ]
Baradaran, Behzad [1 ]
Shaaker, Maghsod [1 ]
Mehdizadeh, Amir [1 ]
机构：
[1] Tabriz Univ Med Sci, Tabriz, Iran
来源：
CLINICAL BIOCHEMISTRY | 2011年 / 44卷 / 13期
关键词：
PPAR alpha; Fatty acids; HepG2;
D O I：
10.1016/j.clinbiochem.2011.08.652
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [21] Peroxisome proliferator-activated receptor-/ modulates mast cell phenotype
    Yao, Pei-Li
    Morales, Jose L.
    Gonzalez, Frank J.
    Peters, Jeffrey M.
    IMMUNOLOGY, 2017, 150 (04) : 456 - 467
  • [22] Peroxisome proliferator-activated receptor-γ agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines
    Yang, Y. -C.
    Tsao, Y. -P.
    Ho, T. -C.
    Choung, I. -P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (02) : 418 - 425
  • [23] Effects of peroxisome proliferator-activated receptor- agonists on the generation of microparticles by monocytes/macrophages
    Neri, Tommaso
    Cordazzo, Cinzia
    Carmazzi, Yuri
    Petrini, Silvia
    Balia, Cristina
    Stefanelli, Fabio
    Amoruso, Angela
    Brunelleschi, Sandra
    Breschi, Maria Cristina
    Pedrinelli, Roberto
    Paggiaro, Pierluigi
    Celi, Alessandro
    CARDIOVASCULAR RESEARCH, 2012, 94 (03) : 537 - 544
  • [24] Peroxisome proliferator-activated receptor-γ agonists suppress adrenocortical tumor cell proliferation and induce differentiation
    Betz, MJ
    Shapiro, I
    Fassnacht, M
    Hahner, S
    Reincke, M
    Beuschlein, F
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (07): : 3886 - 3896
  • [25] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AGONISTS PROTECT OLIGODENDROCYTE FROM MITOCHONDRIAL STRESS
    De Simone, R.
    Bernardo, A.
    De Nuccio, C.
    Visentin, S.
    Minghetti, L.
    GLIA, 2013, 61 : S164 - S164
  • [26] Peroxisome proliferator-activated receptor-γ agonists attenuate biofilm formation by Pseudomonas aeruginosa
    Bedi, Brahmchetna
    Maurice, Nicholas M.
    Ciavatta, Vincent T.
    Lynn, K. Sabrina
    Yuan, Zhihong
    Molina, Samuel A.
    Joo, Myungsoo
    Tyor, William R.
    Goldberg, Joanna B.
    Koval, Michael
    Hart, C. Michael
    Sadikot, Ruxana T.
    FASEB JOURNAL, 2017, 31 (08): : 3608 - 3621
  • [27] Differential hepatic activation of mouse and human peroxisome proliferator-activated receptor-α by perfluorohexane sulfonate
    Khan, Yahya
    Schmidt, Annalee M.
    Oldro, Kyle J.
    Zhu, Xiaoyang
    Kramer, Angelina R.
    Hamilton, Sarah R.
    Bleil, Katherine O.
    Krisko, Ryan M.
    Zitzow, Jeremiah D.
    Tian, Yuan
    Chang, Shu-Ching
    Walter, Vonn
    Cohen, Samuel M.
    Gonzalez, Frank J.
    Patterson, Andrew D.
    Peters, Jeffrey M.
    TOXICOLOGICAL SCIENCES, 2025,
  • [28] Peroxisome proliferator-activated receptor-γ agonists in atherosclerosis:: current evidence and future directions
    Roberts, AW
    Thomas, A
    Rees, A
    Evans, M
    CURRENT OPINION IN LIPIDOLOGY, 2003, 14 (06) : 567 - 573
  • [29] Effects of peroxisome proliferator-activated receptor-γ agonists on central nervous system inflammation
    Kielian, T
    Drew, PD
    JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 71 (03) : 315 - 325
  • [30] Regulation of Peroxisome Proliferator-Activated Receptor-α by MDM2
    Gopinathan, Lakshmi
    Hannon, Daniel B.
    Peters, Jeffrey M.
    Heuvel, John P. Vanden
    TOXICOLOGICAL SCIENCES, 2009, 108 (01) : 48 - 58
12345